Kouki T, Inul T, Yamashiro K, Hachiya T, Ochi Y, Kajita Y, Takasu N, Sato Y, Nagata A
Central Clinical Laboratory, Shiga University of Medical Science, Japan.
Clin Endocrinol (Oxf). 1997 Dec;47(6):693-8. doi: 10.1046/j.1365-2265.1997.3191139.x.
Thyroid stimulation blocking antibodies (TSBAb) inhibit TSH action and may have a role in the pathogenesis of hypothyroidism. In order to study the relationship between blocking and stimulating activities we have examined the biologically active fragments in TSBAb-IgG molecules after papain digestion.
Both thyroid stimulating (TS) activity (cAMP production in thyroid cells) and TSH binding inhibitory (TBI) activity (determined by TSH receptor assay) in sera from patients with primary hypothyroidism were examined after digestion with papain-Sepharose in the presence of cysteine. The digested IgG was separated into unbound (UF) and bound (BF) fractions on a Protein A-Sepharose column. Each fraction was then gel-filtrated on a Sephadex G-100 column.
TS activity was found within one hour after hydrolysis in 5 out of 7 antibodies, then gradually decreased after more prolonged incubation. Both TS and TBI activities in the UF and the BF from Protein A were found in Feb (Mr 50 kD) and the second protein peak (Fc with trace amounts of Fab), respectively. The biological activity in the second protein peak was suggested as being derived from Fab fraction, because the activity bound to the anti-F(ab')2 column. However, the first peak (undigested IgG) in the BF had neither TS nor TSB activity. The TS activity in the retarded fraction (less than Mr 20 kD) in the UF gradually increased with prolonged digestion.
The conversion of Thyroid stimulation blocking antibodies activity to thyroid stimulating activity by papain digestion suggests that the inherent thyroid stimulating activity located in the Fab portion of the IgG molecule is unmasked by papain cleavage. We also suggest that the thyroid stimulating activity in the retarded fraction in the unbound fraction may be released from hydrolysis of the Fab portion of the IgG molecule.
甲状腺刺激阻断抗体(TSBAb)可抑制促甲状腺激素(TSH)的作用,可能在甲状腺功能减退症的发病机制中起作用。为了研究阻断活性与刺激活性之间的关系,我们检测了木瓜蛋白酶消化后TSBAb-IgG分子中的生物活性片段。
在半胱氨酸存在的情况下,用木瓜蛋白酶-琼脂糖消化原发性甲状腺功能减退症患者血清后,检测其甲状腺刺激(TS)活性(甲状腺细胞中环磷酸腺苷(cAMP)的产生)和TSH结合抑制(TBI)活性(通过TSH受体测定法测定)。将消化后的IgG在蛋白A-琼脂糖柱上分离为未结合(UF)和结合(BF)部分。然后将每个部分在葡聚糖凝胶G-100柱上进行凝胶过滤。
7种抗体中有5种在水解后1小时内发现TS活性,随后在更长时间的孵育后逐渐降低。蛋白A的UF和BF中的TS和TBI活性分别在Feb(分子量50 kD)和第二个蛋白峰(含有微量Fab的Fc)中发现。第二个蛋白峰中的生物活性被认为源自Fab部分,因为该活性与抗F(ab')2柱结合。然而,BF中的第一个峰(未消化的IgG)既没有TS活性也没有TSB活性。UF中滞留部分(分子量小于20 kD)的TS活性随着消化时间的延长而逐渐增加。
木瓜蛋白酶消化使甲状腺刺激阻断抗体活性转化为甲状腺刺激活性,这表明IgG分子Fab部分中固有的甲状腺刺激活性被木瓜蛋白酶切割后暴露出来。我们还认为,未结合部分中滞留部分的甲状腺刺激活性可能是由于IgG分子Fab部分的水解而释放出来的。